siRNA therapy decreases triglycerides in patients along with uncommon problem

.RESEARCH STUDY FEATURE.19 September 2024.

Plozasiran reduced triglyceride degrees by 80% as well as reduced the danger of pancreatitis in people along with chronic chylomicronemia, along with or without a genetic prognosis.